Loading
Life sciences · Journal article
Acs Nanoscience Au · September 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Boron carbon oxynitride (BCNO) nanoparticles are attractive boron-rich agents for boron neutron capture therapy (BNCT), yet their polymer-directed self-assembly, structural regulation, and delivery–function relationships remain insufficiently explored. Here, we report a stimuli-responsive polymer–BCNO nanoassembly, mPEG/PS-b-PEI@BCNO, that integrates macromolecular self-assembly with efficient boron utilization for BNCT against pancreatic cancer. The amphiphilic mPEG/PS-b-PEI copolymer was constructed by coupling methoxy poly(ethylene glycol) (mPEG), polystyrene (PS), and poly(ethylenimine) (PEI) through acid-labile Schiff-base linkages. Electrostatic complexation between negatively charged BCNO nanoparticles and cationic PEI, combined with solvent-driven amphiphilic assembly, generated spherical nanoassemblies with tunable morphology, size, and surface charge. Systematic variation of the mPEG/PS ratio revealed that the hydrophobic–hydrophilic balance of the copolymer governs BCNO packing and nanoassembly formation. The optimized mPEG/PS-b-PEI@BCNO nanoassemblies exhibited a uniform diameter of approximately 61 nm, positive surface charge, PEG-mediated colloidal stabilization, and acid-triggered disassembly into smaller BCNO-containing fragments under tumor-relevant acidic conditions. Despite a relatively low BCNO content of approximately 8 wt %, mPEG/PS-b-PEI@BCNO markedly improved boron delivery in UN-KC-6141 pancreatic cancer cells; the nanoassemblies achieved higher boron uptake efficiency than bare BCNO and boronophenylalanine (BPA). In 3D pancreatic tumor spheroids, mPEG/PS-b-PEI@BCNO delivered boron concentrations above the therapeutic threshold for BNCT and exhibited boron utilization efficiencies of 16.64% at pH 7.4 and 10.89% at pH 6.5. Under equivalent 10B dosing, the nanoassemblies produced the strongest BNCT response in 3D spheroids, inducing approximately 52% cell death and significantly outperforming bare BCNO and BPA. These findings demonstrate that polymer-controlled nanoassembly architecture enhances boron utilization without relying solely on high intrinsic boron loading, establishing a design framework for the next-generation BNCT nanodrugs.